In this free webinar, learn about the new compliance
requirements and regulatory adjustments under the Inflation
Reduction Act (IRA). Attendees will discover strategic planning
techniques to drive innovation while maintaining compliance with
the new regulatory framework. The featured speakers will explore
the implications of the IRA on drug development, pricing and market
access and how to mitigate risk and capitalize on new
opportunities.
TORONTO, July 16,
2024 /PRNewswire-PRWeb/ -- Discover an informative
webinar that focuses on strategies and insights needed to comply
with the Inflation Reduction Act (IRA) and capitalize on its new
provisions for drug development, pricing and market access in the
biopharmaceutical industry.
This webinar focuses on equipping commercial and market access
professionals with the knowledge and strategies needed to adjust
effectively to the IRA's provisions.
With the Inflation Reduction Act (IRA) now a cornerstone of
modern healthcare legislation, adapting to its mandates is not only
advisable but essential. This webinar focuses on equipping
commercial and market access professionals with the knowledge and
strategies needed to adjust effectively to the IRA's
provisions.
In this webinar, attendees will:
- LEARN the new compliance requirements and regulatory
adjustments under the IRA
- EXPLORE the implications of the IRA on drug development,
pricing and market access, and how to mitigate risk and capitalize
on new opportunities
- DISCOVER strategic planning techniques to continue driving
innovation while maintaining compliance with the new regulatory
framework
Do not miss this opportunity to understand the enduring nature
of these changes, the scope of data requirements and the strategic
implications on drug development, pricing and market access,
ensuring organizations not only comply but excel.
Register for this webinar today to understand how to navigate
the complexities of the Inflation Reduction Act and its impact on
biopharmaceuticals and the healthcare industry.
Join experts from Syneos Health, Tiffany
McCaslin, Managing Director, Value & Access Consulting;
and Peter Zou, PhD, Director, Value
& Access Consulting, for the live webinar on Tuesday, August 06, 2024, at 11am EDT (4pm
BST/UK).
For more information, or to register for this event, visit Adapt
or Fall Behind: Mastering the Inflation Reduction Act's Impact on
Biopharmaceutical Market Access.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading
provider of educational webinars and digital content to the global
life science, food, healthcare and medical device communities.
Every year, thousands of industry practitioners (from
pharmaceutical, biotechnology, food, healthcare and medical device
companies, private & academic research institutions, healthcare
centers, etc.) turn to Xtalks for access to quality content. Xtalks
helps professionals stay current with industry developments,
regulations and jobs. Xtalks webinars also provide perspectives on
key issues from top industry thought leaders and service
providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit
https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1
(416) 977-6555 x371, skumar@xtalks.com, https://xtalks.com
View original content to download
multimedia:https://www.prweb.com/releases/adapt-or-fall-behind-mastering-the-inflation-reduction-acts-impact-on-biopharmaceutical-market-access-upcoming-webinar-hosted-by-xtalks-302197860.html
SOURCE Xtalks